Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$955000.0.

  • Palisade Bio's Change in Accured Expenses fell 487500.0% to -$955000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $547000.0, marking a year-over-year increase of 15091.74%. This contributed to the annual value of $818000.0 for FY2024, which is 26626.02% up from last year.
  • Latest data reveals that Palisade Bio reported Change in Accured Expenses of -$955000.0 as of Q3 2025, which was down 487500.0% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Change in Accured Expenses registered a high of $1.8 million during Q2 2025, and its lowest value of -$970000.0 during Q1 2023.
  • For the 5-year period, Palisade Bio's Change in Accured Expenses averaged around $72687.5, with its median value being $12000.0 (2022).
  • In the last 5 years, Palisade Bio's Change in Accured Expenses skyrocketed by 1497500.0% in 2023 and then tumbled by 487500.0% in 2025.
  • Palisade Bio's Change in Accured Expenses (Quarter) stood at $183000.0 in 2021, then plummeted by 267.76% to -$307000.0 in 2022, then fell by 0.33% to -$308000.0 in 2023, then soared by 194.81% to $292000.0 in 2024, then tumbled by 427.05% to -$955000.0 in 2025.
  • Its last three reported values are -$955000.0 in Q3 2025, $1.8 million for Q2 2025, and -$604000.0 during Q1 2025.